Encompass Health Corporation (EHC)
Encompass Health Statistics
Share Statistics
Encompass Health has 100.97M shares outstanding. The number of shares has increased by 0.02% in one year.
| Shares Outstanding | 100.97M |
| Shares Change (YoY) | 0.02% |
| Shares Change (QoQ) | -0.04% |
| Owned by Institutions (%) | 95.46% |
| Shares Floating | 99.39M |
| Failed to Deliver (FTD) Shares | 398 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 2.5M, so 2.48% of the outstanding shares have been sold short.
| Short Interest | 2.5M |
| Short % of Shares Out | 2.48% |
| Short % of Float | 2.8% |
| Short Ratio (days to cover) | 2.4 |
Valuation Ratios
The PE ratio is 20.25 and the forward PE ratio is 21.64. Encompass Health's PEG ratio is 0.7.
| PE Ratio | 20.25 |
| Forward PE | 21.64 |
| PS Ratio | 1.72 |
| Forward PS | 1.6 |
| PB Ratio | 4.46 |
| P/FCF Ratio | -14.29 |
| PEG Ratio | 0.7 |
Enterprise Valuation
Encompass Health has an Enterprise Value (EV) of 9.49B.
| EV / Sales | 1.77 |
| EV / EBITDA | 8 |
| EV / EBIT | -3062.89 |
| EV / FCF | -14.71 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.05 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.3 |
| Debt / FCF | -0.55 |
| Interest Coverage | 6.29 |
Financial Efficiency
Return on Equity is 22.05% and Return on Invested Capital is 11.8%.
| Return on Equity | 22.05% |
| Return on Assets | 6.97% |
| Return on Invested Capital | 11.8% |
| Revenue Per Employee | $228.03K |
| Profits Per Employee | $19.34K |
| Employee Count | 23,564 |
| Asset Turnover | 0.82 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 150.2M |
| Effective Tax Rate | 20.04% |
Stock Price Statistics
The stock price has increased by 39.01% in the last 52 weeks. The beta is 0.76, so Encompass Health's price volatility has been higher than the market average.
| Beta | 0.76 |
| 52-Week Price Change | 39.01% |
| 50-Day Moving Average | 100.64 |
| 200-Day Moving Average | 96.36 |
| Relative Strength Index (RSI) | 71.92 |
| Average Volume (20 Days) | 861.55K |
Income Statement
In the last 12 months, Encompass Health had revenue of 5.37B and earned 455.7M in profits. Earnings per share was 4.56.
| Revenue | 5.37B |
| Gross Profit | 2.47B |
| Operating Income | 864.5M |
| Net Income | 455.7M |
| EBITDA | 1.19B |
| EBIT | 887M |
| Earnings Per Share (EPS) | 4.56 |
Balance Sheet
The company has 85.4M in cash and 354.6M in debt, giving a net cash position of -269.2M.
| Cash & Cash Equivalents | 85.4M |
| Total Debt | 354.6M |
| Net Cash | -269.2M |
| Retained Earnings | 796.7M |
| Total Assets | 6.64B |
| Working Capital | 54.9M |
Cash Flow
In the last 12 months, operating cash flow was -3.1M and capital expenditures -642.5M, giving a free cash flow of -645.6M.
| Operating Cash Flow | -3.1M |
| Capital Expenditures | -642.5M |
| Free Cash Flow | -645.6M |
| FCF Per Share | -6.46 |
Margins
Gross margin is 46.01%, with operating and profit margins of 16.09% and 8.48%.
| Gross Margin | 46.01% |
| Operating Margin | 16.09% |
| Pretax Margin | 13.95% |
| Profit Margin | 8.48% |
| EBITDA Margin | 22.08% |
| EBIT Margin | 16.09% |
| FCF Margin | -12.02% |
Dividends & Yields
EHC pays an annual dividend of $0.81, which amounts to a dividend yield of 0.65%.
| Dividend Per Share | $0.81 |
| Dividend Yield | 0.65% |
| Dividend Growth (YoY) | 13.33% |
| Payout Ratio | 16.67% |
| Earnings Yield | 4.94% |
| FCF Yield | -7% |
Analyst Forecast
The average price target for EHC is $125, which is 7.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $125 |
| Price Target Difference | 7.8% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Jul 1, 2022. It was a forward split with a ratio of 1257:1000.
| Last Split Date | Jul 1, 2022 |
| Split Type | forward |
| Split Ratio | 1257:1000 |
Scores
| Altman Z-Score | 3.17 |
| Piotroski F-Score | 7 |